[Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America].
The global spread of MRSA means it is now a pathogen of worldwide public health concern. Within Latin America, MRSA is highly prevalent, with the proportion of S. aureus isolates that are methicillin-resistant on the rise, yet resources for managing the infection are limited. While several guidelines exist for the treatment of MRSA infections, many are written for the North American or European setting and need adaptation for use in Latin America. In this article, we aim to emphasize the importance of appropriate treatment of MRSA in the healthcare and community settings of Latin America. We present a summary of the available guidelines and antibiotics, and discuss particular considerations for clinicians treating MRSA in Latin America.
Departmento de Medicina Interna, División de Enfermedades Pulmonares, Hospital de Clínicas, Universidad de Buenos Aires, Argentina. cymluna@fmed.uba.ar
Carlos M
CM
Luna
Eduardo
E
Rodríguez-Noriega
Luis
L
Bavestrello
Eduardo
E
Gotuzzo
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D006801:Humans; D007843:Latin America; D008171:Lung Diseases / Q000188:drug therapy; D055624:Methicillin-Resistant Staphylococcus aureus; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents